Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HER2-Positive Primary Breast Cancer
×
trastuzumab deruxtecan
×
Clear all
Filters
3
NCT04622319
2025-05-09
DESTINY-Breast05
Daiichi Sankyo
Phase 3
Active not recruiting
1,600 enrolled